melbourne shareholder briefing, page-17

Thanks guys for the compliments, just wanted to do my bit as I enjoy reading the Phylogica thread and contributions from the regulars :)

In regards to the 100 bagger comment, I agree with redcapri, wouldn't take too much from it, Nick wasn't too keen to respond naturally but he is very passionate about the company as is Paul and they did mention that there is no other company that they are aware of that can do everything that they do.

I personally think $0.40 is where they may get up to, but $4 is probably wishful at this point in time.

With relation to second stage of first 3 deals, I don't unfortunately have any notes about timeframe Hesk, but I think Roche are currently evaluating data so hopefully they aren't too far off.